Wasim, Hanif, Al-Daghri , Nasser M., Chetty, Raja , McTernan, P. G. (Philip G.), Barnett, A. H. (Anthony H.), 1951- and Kumar, Sudhesh. (2006) Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in south-Asians. Cardiovascular Diabetology, Vol.5 (No.10). ISSN 1475-2840

Preview

PDF WRAP_Kumar_relationship_serum.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Download (252Kb)

Abstract

Objectives South-Asians have lower adiponectin levels compared to Caucasians. It was not clear however, if this intrinsic feature is related to aspects of glucose metabolism. This study aims to determine the relationship between body fat distribution and adipocytokine in South-Asian subjects by measuring serum adipocytokines, adiposity, insulinemia, and glucose tolerance levels. Methods In this cross-sectional study, 150 South-Asians (80 males, 70 females) were included, 60 had NGT (Control group, Age 51.33 ± 11.5, BMI 27 ± 2.3), 60 had IGT (Age 57.7 ± 12.5, BMI 27.2 ± 2.7), 30 had type 2 DM (Age 49.5 ± 10.9, BMI 28 ± 1.7). Measures of adiposity, adipocytokines and other metabolic parameters were determined. Parameters were measured using the following: a) Plasma glucose by glucose oxidase method b) CRP by immunoturbidimetric method (Roche/Hitachi analyser) c) insulin by Medgenix INS-ELISA immunoenzymetric assay by Biosource (Belgium) d) Leptin, Adiponectin by radioimmunoassay kits by Linco Research (St. Charles MO) e) Resistin by immunoassay kits by Phoenix Pharmaceuticals INC (530 Harbor Boulevard, Belmont CA 94002, USA). Results Adiponectin concentrations were highest in NGT, decreased in IGT and lowest in DMT2, (both p < 0.01). Leptin was significantly higher in DMT2 than IGT and NGT p = 0.02 and 0.04 respectively. There was a significant positive relationships between log adiponectin and 2-hr insulin values, p = 0.028 and history of hypertensions and a ischemic heart disease p = 0.008 with R = 0.65. There was a significant inverse correlation between log adiponectin and resistin, p < 0.01. Conclusion Resistin levels had an inverse correlation with adiponectin levels, indicating an inverse relationship between pro-inflammatory cytokines and adiponectin. Adiponectin levels were related to glucose tolerance.

Item Type:	Journal Article
Subjects:	R Medicine > R Medicine (General)
Divisions:	Faculty of Medicine > Warwick Medical School > Clinical Sciences Research Institute (CSRI) Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Adipose tissues, Asians -- Health and hygiene, Blood sugar
Journal or Publication Title:	Cardiovascular Diabetology
Publisher:	BioMed Central Ltd.
ISSN:	1475-2840
Date:	2 May 2006
Volume:	Vol.5
Number:	No.10
Identification Number:	10.1186/1475-2840-5-10
Status:	Peer Reviewed
Access rights to Published version:	Open Access
References:	1. Chandran M, Phillips SA, Ciaraldi TP, Henry RR: Adiponectin: More Than Just Another Fat Cell Hormone? Diabetes Care 2003, 26:2442-2450. 2. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochemical & Biophysical Research Communications 1996, 221:286-289. 3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical & Biophysical Research Communications 1999, 257(1):79-83. 4. Stejskal D, Ruzicka V, Adamovska S, Jurakova R, Proskova J, Jedelsky L, Bartek J: Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003, 147(2):167-172. 5. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y: Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Internal Medicine 1999, 38(2):202-206. 6. Matsuzawa Y, Funahashi T, Nakamura T: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte- derived bioactive substances. Annals of the New York Academy of Sciences 1999, 892:146-154. 7. Matsuzawa Y: Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005, 6(2):7-14. 8. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis & Vascular Biology 2000, 20(6):1595-1599. 9. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology & Metabolism 2001, 86(5):1930-1935. 10. Cancello R, Tounian A, Poitou C, Clement K: Adiposity signals, genetic and bodweight regulation in humans. Diabetes Metab 2004, 30(3):215-227. 11. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. [erratum appears in J Clin Endocrinol Metab 2002 Apr;87(4):1626]. Journal of Clinical Endocrinology & Metabolism 2001, 86(8):3815-3819. 12. Houston GW: The prevalence of diabetes mellitus ina typical English community. Journal of the Royal College of Physicians of London 1985, 19:248-250. 13. Williams R: Diabetes Mellitus. In Health care needs assessment Edited by: Stevens A, Raftery J. Oxford: Radcliffe Medcial Press; 1994:31-57. 14. Dhawan J, Bray CL, Warburton R, Ghambhir DS, Morris J: Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect? [see comments.]. British Heart Journal 1994, 72(5):413-421. 15. Cruikshank JK, Cooper J, Burnett M, MacDuff J, Drubra U: Ethnic diffrences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 1991, 338:842-847. 16. Chatruvedi N, Mckeigue PM: Methods for epidemiological surveys of ethnic minority groups. J Epidemiol Community Health 1994, 48:107-111. 17. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG: Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993, 87(1):152-161. 18. Valsamakis G, Chetty R, McTernan PG, Al-Daghri NM, Barnett AH, Kumar S: Fasting adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab 2003, 5:131-135. 19. Flier JS, Kahn CR, Roth J: Receptor, antireceptor antibodies and mechanism of insulin resistance. N Eng J Med 1979, 300(8):413-419. 20. Zhongmin MA: Radioimmunoassay of leptin in human plasma. Clinical Chemistry 1996, 42:942-946. 21. Postman T, Kiessig ST: Enzyme immunoassay techniques: An overview. Immunol Methods 1992, 150:5-21. 22. Crz M, Garcia-Macedo R, Garcia-Valerio Y, Gutierrez M, Medina- Navarro R, Duran G, Wacher N, Kumate J: Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care 2004, 27(6):1451-1453. 23. Yoshida H, Hirowatari Y, Kurosawa H, Tada N: Implications of decreased serum adiponectin for type IIb hyperlipidemia and increased cholesterol levels of very low density lipoprotein in type 2 diabetes patients. Clin Sci (Lond) 2005. 24. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43(11):1271-1278. 25. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(11):4854-4858. 26. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259(5091):87-91. 27. Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S, Kamon J, Kobayashi M, Suzuki R, Hara K: Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004, 279(29):30817-30822. 28. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita Y, Funahashi T, Matsuzawa Y: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100(25):2473-2476. 29. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Hansen BC, Matsuzawa Y: Circulating concentrations of the adipocyte protein adiponectin are decrease in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126-1133. 30. Bogan JS, Lodish HF: Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 anf GLUT4. J Cell Biol 1999, 146:609-620. 31. Smith U, Axelsen M, Carvalho E, Eliasson B, Jansson PA, Wesslau C: Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 1999, 892:119-126. 32. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM: The effect of thiazolidinediones on plasma adiponectin levles, in normal, obese and type 2 diabetic subjects. Diabetes 2002, 51:2968-2974. 33. Kwon K, Jung SH, Choi C, Park SH: Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women. Int J Cardiol 2005, 101(3):385-390. 34. Kawano T, Saito T, Yasu T, Saito T, Nakamura T, Namai K, Tamemoto H, Kawakami M, Saito M, Ishikawa SE: Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease. Metabolism 2005, 54(5):653-656. 35. de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti KG: Hyperleptinaemia: the missing link in the, metabolic syndrome? Diabetic Medicine 1997, 14(3):200-208. 36. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice.[comment]. Science 1995, 269(5223):540-543. 37. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, et al.: Serum immunoreactive-leptin concentrations in normalweight and obese humans.[comment]. New England Journal of Medicine 1996, 334(5):292-295. 38. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 1995, 377(6549):527-529.
URI:	http://wrap.warwick.ac.uk/id/eprint/550

Request changes to a record

Actions (login required)

View Item